Utah Retirement Systems Adaptive Biotechnologies Corp Transaction History

Utah Retirement Systems

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 16, 2021	SELL	$30.02 - $39.87 $168,112 - $223,272	-5,600 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$32.22 - $44.59 $180,432 - $249,704	5,600 New	5,600 $229,000
Q1 2021 May 17, 2021	SELL	$37.26 - $67.74 $145,314 - $264,186	-3,900 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$45.01 - $65.47 $175,539 - $255,333	3,900 New	3,900 $231,000

201

146M

68.8K

42.5K

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $631M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

Get notified when there are updates to the investment portfolio of Utah Retirement Systems, based on Form 13F filings with the SEC.

Stay updated on Utah Retirement Systems with notifications on news.